|Bid||0.8800 x 0|
|Ask||0.9100 x 0|
|Day's Range||0.8800 - 0.9200|
|52 Week Range||0.5600 - 1.5200|
|Beta (5Y Monthly)||0.30|
|PE Ratio (TTM)||62.86|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Has entered into an agreement with Astellas Pharma Inc. to evaluate ZEN-3694, Zenith’s leading BET inhibitor, ...
Announced today the publishing of an article titled: "Bromodomain and extraterminal protein inhibitor, ...
If you want to know who really controls Resverlogix Corp. ( TSE:RVX ), then you'll have to look at the makeup of its...